Companies / Mediar Therapeutics

Mediar Therapeutics

Boston, Massachusetts, United States

Mediar Therapeutics is developing treatments for fibrotic diseases by targeting the myofibroblast cell

Mediar Therapeutics, based in Boston, Massachusetts, United States, has 11 investors on file, among them Agent Capital, Amplitude Ventures and Asahi Kasei Ventures. Its latest round on record is Series B, 7 Jan 2026. Its site was last checked 12 Nov 2026: site answers.

mediartx.com

Funding

1 round on record

Latest roundSeries B7 Jan 2026

Since that round10 monthsno later round on record

Investors in its rounds53 with a VCinfo profile

Jan 2026Series BLed by Amplitude Ventures, with Longwood Fund, Asahi Kasei Ventures and 2 others

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

11 investors on file

Investor	Evidence	Type
Agent Capital	Portfolio page	Venture capital
Amplitude Ventures	Portfolio page	Venture capital
Asahi Kasei Ventures	Portfolio page	Corporate VC
Longwood Fund	Portfolio page	Venture capital
Mission BioCapital	Portfolio page	Venture capital
Novartis Venture Fund	Portfolio page	Corporate VC
Ono Venture Investment	Portfolio page	Corporate VC
Pureos Bioventures	Portfolio page	Venture capital
ShangBay Capital	Portfolio page	Venture capital
Sofinnova Partners	Portfolio page	Venture capital
Viva BioInnovator	Portfolio page	Corporate VC

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

At a glance

Latest round: Series B, 7 Jan 2026
Investors on file: 11
Founded: 2019
Employees: 11-50
Headquarters: Boston, Massachusetts, United States
Hiring: Careers page
Site: Answers
Last checked: 12 Nov 2026

Company data by Fundup AI.

Backed by the same investors

Companies sharing two or more investors with Mediar Therapeutics.

Flare Therapeutics3 shared

Avation Medical2 shared

Citryll B.V.2 shared

Epi Biologics2 shared

GlycoEra2 shared

Glycomine2 shared

Get this company as JSON

GET /v1/companies/mediartx.com
GET /v1/companies/mediartx.com/investors
GET /v1/companies/mediartx.com/news

API docs · Get a free key · Your API key

Raising a round?

See which investors fit your startup, ranked by what they actually back.

Check investor fit

Free account · no card

Get Mediar Therapeutics and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Agent Capital adds a company.

Work email, sign-in link by email. Already have an account? Log in

Your API key Read the docs

Ask AI5 plain-English investor searches a day
Full listsEvery portfolio row and two-firm overlap
API and MCP100 REST or MCP calls a month, one key
AlertsFollow 5 investors for portfolio and fund changes

VCinfo API

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/mediartx.com/investors

# also
GET /v1/companies/mediartx.com
GET /v1/companies/mediartx.com/news

The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing